STING1 and colitis: Thus, one possible explanation as to why the co-administration of DSS and a STING agonist led to a dramatic worsening of colitis, is that the STING agonists increased pro-inflammatory activities in the M1 cells and repolarized M2 cells towards an M1-like phenotype.